These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Parathyroid hormone-responsive Smad3-related factor, Tmem119, promotes osteoblast differentiation and interacts with the bone morphogenetic protein-Runx2 pathway. Hisa I; Inoue Y; Hendy GN; Canaff L; Kitazawa R; Kitazawa S; Komori T; Sugimoto T; Seino S; Kaji H J Biol Chem; 2011 Mar; 286(11):9787-96. PubMed ID: 21239498 [TBL] [Abstract][Full Text] [Related]
10. Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation. Kurisaki K; Kurisaki A; Valcourt U; Terentiev AA; Pardali K; Ten Dijke P; Heldin CH; Ericsson J; Moustakas A Mol Cell Biol; 2003 Jul; 23(13):4494-510. PubMed ID: 12808092 [TBL] [Abstract][Full Text] [Related]
11. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895 [TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone-Smad3 axis exerts anti-apoptotic action and augments anabolic action of transforming growth factor beta in osteoblasts. Sowa H; Kaji H; Iu MF; Tsukamoto T; Sugimoto T; Chihara K J Biol Chem; 2003 Dec; 278(52):52240-52. PubMed ID: 14517210 [TBL] [Abstract][Full Text] [Related]
13. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Lee KS; Kim HJ; Li QL; Chi XZ; Ueta C; Komori T; Wozney JM; Kim EG; Choi JY; Ryoo HM; Bae SC Mol Cell Biol; 2000 Dec; 20(23):8783-92. PubMed ID: 11073979 [TBL] [Abstract][Full Text] [Related]
14. Smurf1 facilitates myogenic differentiation and antagonizes the bone morphogenetic protein-2-induced osteoblast conversion by targeting Smad5 for degradation. Ying SX; Hussain ZJ; Zhang YE J Biol Chem; 2003 Oct; 278(40):39029-36. PubMed ID: 12871975 [TBL] [Abstract][Full Text] [Related]
15. BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. Lee MH; Kim YJ; Kim HJ; Park HD; Kang AR; Kyung HM; Sung JH; Wozney JM; Kim HJ; Ryoo HM J Biol Chem; 2003 Sep; 278(36):34387-94. PubMed ID: 12815054 [TBL] [Abstract][Full Text] [Related]
16. Role of menin in bone development. Kaji H; Canaff L; Hendy GN Adv Exp Med Biol; 2009; 668():59-67. PubMed ID: 20175453 [TBL] [Abstract][Full Text] [Related]
17. Activations of ERK1/2 and JNK by transforming growth factor beta negatively regulate Smad3-induced alkaline phosphatase activity and mineralization in mouse osteoblastic cells. Sowa H; Kaji H; Yamaguchi T; Sugimoto T; Chihara K J Biol Chem; 2002 Sep; 277(39):36024-31. PubMed ID: 12130649 [TBL] [Abstract][Full Text] [Related]
18. Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts. Yamamoto N; Akiyama S; Katagiri T; Namiki M; Kurokawa T; Suda T Biochem Biophys Res Commun; 1997 Sep; 238(2):574-80. PubMed ID: 9299554 [TBL] [Abstract][Full Text] [Related]
19. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype. Phimphilai M; Zhao Z; Boules H; Roca H; Franceschi RT J Bone Miner Res; 2006 Apr; 21(4):637-46. PubMed ID: 16598384 [TBL] [Abstract][Full Text] [Related]
20. TRIM33 is essential for osteoblast proliferation and differentiation via BMP pathway. Guo J; Qin W; Xing Q; Gao M; Wei F; Song Z; Chen L; Lin Y; Gao X; Lin Z J Cell Physiol; 2017 Nov; 232(11):3158-3169. PubMed ID: 28063228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]